Matthew Ferriday

Matthew Ferriday
Vaccines Business Unit Director, AstraZeneca UKMC 

Matthew has over 15 years experience working in commercial roles in the pharmaceutical industry across Abbott, GSK and AZ.  During this time Matthew has developed deep commercial expertise working in speciality care therapy areas most notably infectious diseases, virology and vaccines in different countries and regions around the world.

Passionate about connecting the science to patients Matthew has led projects to break down barriers in access which included bringing at home administration for a biologic to treat severe asthma.  Currently, Matthew leads the Vaccines and Immune Therapy for AstraZeneca UK which covers influenza, Respiratory Syncytial Virus and COVID-19.

Back to top